339 results on '"Vekeman, Francis"'
Search Results
2. Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence
3. Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
4. Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysis
5. Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data.
6. Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with a Senior Executive at an International Life Science Company
7. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting
8. P-250 The relationship of extramedullary disease and high-risk cytogenetics on real-world outcomes among patients with triple-class exposed multiple myeloma
9. P362: OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING HEMATOPOIETIC CELL TRANSPLANTATION USING REAL-WORLD DATA FROM HARMONY
10. Assessment of treatment patterns and healthcare costs associated with probable Lennox–Gastaut syndrome
11. Effects of variations in access to care for children with atopic dermatitis
12. Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia
13. Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center
14. Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community setting
15. Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices
16. Is Addition of Vasodilators to Loop Diuretics of Value in the Care of Hospitalized Acute Heart Failure Patients? Real-World Evidence From a Retrospective Analysis of a Large United States Hospital Database
17. Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
18. Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting
19. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
20. Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis
21. Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
22. Use of Antipsychotic Drugs in Patients with Alzheimer’s Disease Treated with Rivastigmine versus Donepezil: A Retrospective, Parallel-Cohort, Hypothesis-Generating Study
23. Additional file 1 of Effects of variations in access to care for children with atopic dermatitis
24. Final Results from the Multicenter COMPACT Study of Complications in Patients with Sickle Cell Disease (SCD) and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review: 358.
25. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs
26. Risk of Hepatotoxicity-Related Hospitalizations among Patients Treated with Opioid/Acetaminophen Combination Prescription Pain Medications
27. Reply to Comparison of Hospitalization Risk and Associated Costs Among Patients Receiving Sargramostim, Filgrastim, and Pegfilgrastim for Chemotherapy-Induced Neutropenia
28. Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia
29. Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin
30. An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte– or granulocyte-macrophage–colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach
31. An assessment of erythroid response to epoetin (alpha) as a single agent versus in combination with granulocyte- or granulocyte-macrophage - colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach
32. Dose and cost comparison of erythropoietic agents in the inpatient hospital setting
33. Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study
34. Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
35. Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia
36. Development of a classifier to identify patients with probable Lennox–Gastaut syndrome in health insurance claims databases via random forest methodology
37. Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus
38. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis
39. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets
40. Reduced Healthcare Costs Among Clobazam-Treated Patients With Lennox–Gastaut Syndrome (P6.287)
41. Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
42. Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LAR
43. Prevalence and economic burden of extrahepatic manifestations of hepatitis C virus are underestimated but can be improved with therapy
44. Association between duration of somatostatin analogs (SSAs) use and quality of life in patients with carcinoid syndrome in the United States based on the FACT-G instrument.
45. SP020HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX AND ASSOCIATED MANIFESTATIONS
46. Healthcare Resource Utilization Among Patients With Lennox-Gastaut Syndrome Treated With Clobazam (P4.103)
47. Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population
48. Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving second-line (2L) chemotherapy (CT) vs alternative androgen receptor-targeted agents (ARTA) after lack of response to first-line (1L) ARTA in US community oncology practices.
49. Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community Setting
50. Can social media data lead to earlier detection of drug‐related adverse events?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.